September 06, 2008
Home
About
Submit Press Release
PR Firms
Editors/Journalists
Search Archives
 
News Releases by Category  
News by Country  
News by MSA  
All News for Today  
Browse News by Day  
News by Trackbacks  
All Press Releases for May 28, 2005 Subscribe to this News Feed  
 

Meditoxofpalmbeach Offers A New Approach to Opiate Dependency

Download this press release as an Adobe PDF document.

Treatment of opiate dependency has traditionally used methadone. Meditoxofpalmbeach has offered a new treatment to successfully treat the individual who is addicted to opiate based drugs.

West Palm Beach, FL (PRWEB) May 28, 2005 -- Meditox of Palm Beach is an outpatient medical clinic in West Palm Beach, Florida that utilizes a new treatment protocol, the Palm Beach Method, designed specifically for opiate dependency. The clinic treats addiction for Oxycontin, Lortab, Percocet, Hydrocodone, Heroin and all other opiod pain killers. Meditox also specializes in addiction to Methadone.

The philosophy of this new outpatient detoxification program draws upon recent breakthroughs in science and technology which have given rise to the discovery of medications like Buprenorphine (Burpenex, Subutex, Suboxone) designed for the safe and comfortable withdrawal from opiate addiction. The Palm Beach Method was created specifically for high functioning, motivated people who, when joining the program, receive individual attention and guidance (detox coaching") from a team of case managers and addiction specialists. This approach frees the patient from the bondage of chemical dependency without the necessity of hospitalization or rehab. The patient returns to his or her work or studies, allowing them to safely and comfortably return to their lives during the detoxification period.

Buprenorphine, a derivative of thebaine, is an opioid that has been marketed in the United States as the Schedule V parenteral analgesic Buprenex. In 2002, based on a reevaluation of available evidence regarding the potential for abuse, diversion, addiction, and side effects, the DEA reclassified buprenorphine from a Schedule V to a Schedule III narcotic.

Meditox of Palm Beach also offers a medical solution to Methadone dependency that represents cutting edge, out of the box thinking for those seeking freedom from addiction to Methadone. The medical protocol for Methadone treatment is different from the clinics treatment for conventional opiate dependency, but Meditox is able to eliminate Methadone dependency within seven weeks without the aches and pains of withdrawal. Their unique medical protocol is also done entirely on an outpatient basis.

The Palm Beach Method allows a patient, while under the supervision and care of a medical team of experts in addiction, to withdraw in comfort from substance dependency as they continue to get on with life. The Palm Beach Method is different from other treatment programs because it is modified for each patient, taking into consideration not only their medical history, but their personal issues as well. It offers a holistic, bio-psycho-social approach. This is not cookie-cutter medicine. The Palm Beach Method is a program created to suit the needs of the individual - one patient at a time.

See more at www.meditoxofpalmbeach.com

Stuart Birnbaum
1-866-633-4869
meditoxpalmbeach@aol.com

###


See the original story at: http://www.prweb.com/releases/2005/05/prweb245550.htm
Other Releases by this Member
Email this story to a colleague
Printer Friendly Version
Bookmark with del.icio.us
Bookmark with Y!MyWeb
Submit to Digg
Stuart Birnbaum
Meditox of Palm Beach
1-866-633-4869
Email us Here

There are no multimedia files attached to this release. If this is your release you may add images or other multimedia files through your login.

If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2007, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright